Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 8/20 | 0.59 |
| ▸ | RAB9A | P51151 | 6/20 | 0.59 |
| ▸ | NPC1 | O15118 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.46 |
| ▸ | MPO | P05164 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | RRM1 | P23921 | 1/20 | 0.42 |
| ▸ | RRM2 | P31350 | 1/20 | 0.42 |
| ▸ | RRM2B | Q7LG56 | 1/20 | 0.42 |
| ▸ | MITF | O75030 | 2/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5776311 | 0.80 | MPO (0.42) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL5776306 | 0.80 | MPO (0.42) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL11674398 | 0.79 | NOX1 (0.74) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL11674396 | 0.79 | NOX1 (0.74) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL11434619 | 0.79 | NOX1 (0.74) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL11434621 | 0.79 | NOX1 (0.74) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL5779169 | 0.79 | MPO (0.72) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL5779166 | 0.79 | MPO (0.72) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL5778992 | 0.76 | NOX1 (0.76) | GAARAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL5778986 | 0.76 | NOX1 (0.76) | GAARAB9ANPC1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060276433-A1 | Hydrazone derivative | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| EP-1612204-A1 | HYDRAZONE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276433-A1 | Hydrazone derivative | APP, PRNP, HTT | GAA 3175/4885RAB9A 3127/4885NPC1 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.